A 45-year-old woman is diagnosed with severe major depressive disorder without psychotic features. Place the following therapeutic interventions in the most appropriate chronological sequence of standard stepped-care escalation, assuming the patient exhibits an inadequate or partial response at each preceding step.
- 1Initiate monotherapy with a first-line antidepressant such as a selective serotonin reuptake inhibitor (SSRI).
- 2Optimize the dose of the initial agent or switch to an alternative first-line antidepressant.
- 3Augment the current regimen with a non-antidepressant agent (e.g., an atypical antipsychotic or lithium).
- 4Refer for somatic therapies such as electroconvulsive therapy (ECT).
Answer
The correct sequence for escalating treatment in major depressive disorder is: 1) Initiate first-line monotherapy, 2) Switch to an alternative first-line agent or optimize dose, 3) Augment with a non-antidepressant agent, and 4) Refer for somatic therapies like ECT.
The stepped-care model for major depressive disorder emphasizes minimizing side effects and complexity early in treatment. First-line treatment is SSRI or SNRI monotherapy. If an adequate trial (at least 4-6 weeks at a therapeutic dose) fails, guidelines suggest switching to another antidepressant or adding a second antidepressant with a different mechanism. If multiple antidepressant trials fail, the depression is considered treatment-resistant, and augmentation with non-antidepressant medications (e.g., aripiprazole, lithium, thyroid hormone) is indicated. Finally, for highly refractory cases, interventional treatments like electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS) are recommended as the final step in the sequence.
Step-by-Step Solution
Key Concept
The stepped-care approach to major depressive disorder involves a progressive escalation from SSRI/SNRI monotherapy, to switching agents, to augmentation with non-antidepressants, and ultimately to neuromodulation like ECT for refractory cases.